{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T14:38:56Z","timestamp":1780583936525,"version":"3.54.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,8,4]],"date-time":"2018-08-04T00:00:00Z","timestamp":1533340800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003008","name":"Ministry of Higher Education, Egypt","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003008","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s12032-018-1186-4","type":"journal-article","created":{"date-parts":[[2018,8,4]],"date-time":"2018-08-04T08:23:12Z","timestamp":1533370992000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Broccoli extract improves chemotherapeutic drug efficacy against head\u2013neck squamous cell carcinomas"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4875-7534","authenticated-orcid":false,"given":"Osama A.","family":"Elkashty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramy","family":"Ashry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghada Abu","family":"Elghanam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hieu M.","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyun","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Stegen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5594-359X","authenticated-orcid":false,"given":"Simon D.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,4]]},"reference":[{"issue":"5","key":"1186_CR1","doi-asserted-by":"publisher","first-page":"E359-86","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359-86. https:\/\/doi.org\/10.1002\/ijc.29210 .","journal-title":"Int J Cancer"},{"issue":"4","key":"1186_CR2","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1001\/jamaoncol.2016.5688","volume":"3","author":"C Fitzmaurice","year":"2017","unstructured":"Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the Global Burden of Disease Study. JAMA Oncol. 2017;3(4):524\u201348. https:\/\/doi.org\/10.1001\/jamaoncol.2016.5688 .","journal-title":"JAMA Oncol"},{"issue":"2","key":"1186_CR3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69\u201390. https:\/\/doi.org\/10.3322\/caac.20107 .","journal-title":"CA Cancer J Clin"},{"key":"1186_CR4","doi-asserted-by":"publisher","first-page":"44","DOI":"10.12703\/P6-44","volume":"6","author":"JP Machiels","year":"2014","unstructured":"Machiels JP, Lambrecht M, Hanin FX, Duprez T, Gregoire V, Schmitz S, et al. Advances in the management of squamous cell carcinoma of the head and neck. F1000prime Rep. 2014;6:44. https:\/\/doi.org\/10.12703\/p6-44 .","journal-title":"F1000prime Rep"},{"issue":"2","key":"1186_CR5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3322\/CA.2007.0010","volume":"58","author":"A Jemal","year":"2008","unstructured":"Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008;58(2):71\u201396. https:\/\/doi.org\/10.3322\/ca.2007.0010 .","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"1186_CR6","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","volume":"55","author":"DM Parkin","year":"2005","unstructured":"Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74\u2013108.","journal-title":"CA Cancer J Clin"},{"issue":"47","key":"1186_CR7","doi-asserted-by":"publisher","first-page":"7265","DOI":"10.1038\/sj.onc.1206933","volume":"22","author":"ZH Siddik","year":"2003","unstructured":"Siddik ZH. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene. 2003;22(47):7265\u201379. https:\/\/doi.org\/10.1038\/sj.onc.1206933 .","journal-title":"Oncogene"},{"key":"1186_CR8","doi-asserted-by":"publisher","DOI":"10.14800\/ccm.1266","author":"SA Thomas","year":"2016","unstructured":"Thomas SA, Grami Z, Mehta S, K Patel. Adverse effects of 5-fluorouracil: focus on rare side effects. Cancer Cell Microenviron. 2016; https:\/\/doi.org\/10.14800\/ccm.1266 .","journal-title":"Cancer Cell Microenviron"},{"issue":"9","key":"1186_CR9","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/sj.ki.5002786","volume":"73","author":"N Pabla","year":"2008","unstructured":"Pabla N, Dong Z. Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int. 2008;73(9):994\u20131007. https:\/\/doi.org\/10.1038\/sj.ki.5002786 .","journal-title":"Kidney Int"},{"issue":"6","key":"1186_CR10","doi-asserted-by":"publisher","first-page":"419","DOI":"10.3322\/caac.21204","volume":"63","author":"SB Park","year":"2013","unstructured":"Park SB, Goldstein D, Krishnan AV, Lin CS, Friedlander ML, Cassidy J, et al. Chemotherapy-induced peripheral neurotoxicity: a critical analysis. CA Cancer J Clin. 2013;63(6):419\u201337. https:\/\/doi.org\/10.3322\/caac.21204 .","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"1186_CR11","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/sj.bjc.6600884","volume":"88","author":"FE Jongh De","year":"2003","unstructured":"De Jongh FE, van Veen RN, Veltman SJ, de Wit R, van der Burg ME, van den Bent MJ, et al. Weekly high-dose cisplatin is a feasible treatment option: analysis on prognostic factors for toxicity in 400 patients. Br J Cancer. 2003;88(8):1199\u2013206. https:\/\/doi.org\/10.1038\/sj.bjc.6600884 .","journal-title":"Br J Cancer"},{"issue":"1","key":"1186_CR12","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/med.21377","volume":"36","author":"Z Xiao","year":"2016","unstructured":"Xiao Z, Morris-Natschke SL, Lee KH. Strategies for the optimization of natural leads to anticancer drugs or drug candidates. Med Res Rev. 2016;36(1):32\u201391. https:\/\/doi.org\/10.1002\/med.21377 .","journal-title":"Med Res Rev"},{"key":"1186_CR13","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/978-3-642-38007-5_12","volume":"159","author":"M Lenzi","year":"2014","unstructured":"Lenzi M, Fimognari C, Hrelia P. Sulforaphane as a promising molecule for fighting cancer. Cancer Treat Res. 2014;159:207\u201323. https:\/\/doi.org\/10.1007\/978-3-642-38007-5_12 .","journal-title":"Cancer Treat Res"},{"issue":"20","key":"1186_CR14","doi-asserted-by":"publisher","first-page":"19911","DOI":"10.1074\/jbc.M412443200","volume":"280","author":"SV Singh","year":"2005","unstructured":"Singh SV, Srivastava SK, Choi S, Lew KL, Antosiewicz J, Xiao D, et al. Sulforaphane-induced cell death in human prostate cancer cells is initiated by reactive oxygen species. J Biol Chem. 2005;280(20):19911\u201324. https:\/\/doi.org\/10.1074\/jbc.M412443200 .","journal-title":"J Biol Chem"},{"issue":"20","key":"1186_CR15","doi-asserted-by":"publisher","first-page":"9937","DOI":"10.1158\/0008-5472.CAN-07-1112","volume":"67","author":"G Shen","year":"2007","unstructured":"Shen G, Khor TO, Hu R, Yu S, Nair S, Ho CT, et al. Chemoprevention of familial adenomatous polyposis by natural dietary compounds sulforaphane and dibenzoylmethane alone and in combination in ApcMin\/+ mouse. Cancer Res. 2007;67(20):9937\u201344. https:\/\/doi.org\/10.1158\/0008-5472.can-07-1112 .","journal-title":"Cancer Res"},{"issue":"13","key":"1186_CR16","doi-asserted-by":"publisher","first-page":"6409","DOI":"10.1158\/0008-5472.CAN-07-0340","volume":"67","author":"L Mi","year":"2007","unstructured":"Mi L, Wang X, Govind S, Hood BL, Veenstra TD, Conrads TP, et al. The role of protein binding in induction of apoptosis by phenethyl isothiocyanate and sulforaphane in human non-small lung cancer cells. Cancer Res. 2007;67(13):6409\u201316. https:\/\/doi.org\/10.1158\/0008-5472.can-07-0340 .","journal-title":"Cancer Res"},{"issue":"5","key":"1186_CR17","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1158\/1535-7163.MCT-06-0807","volume":"6","author":"A Herman-Antosiewicz","year":"2007","unstructured":"Herman-Antosiewicz A, Xiao H, Lew KL, Singh SV. Induction of p21 protein protects against sulforaphane-induced mitotic arrest in LNCaP human prostate cancer cell line. Mol Cancer Ther. 2007;6(5):1673\u201381. https:\/\/doi.org\/10.1158\/1535-7163.mct-06-0807 .","journal-title":"Mol Cancer Ther"},{"issue":"28","key":"1186_CR18","doi-asserted-by":"publisher","first-page":"7031","DOI":"10.1021\/jf301981n","volume":"60","author":"LC Lin","year":"2012","unstructured":"Lin LC, Yeh CT, Kuo CC, Lee CM, Yen GC, Wang LS, et al. Sulforaphane potentiates the efficacy of imatinib against chronic leukemia cancer stem cells through enhanced abrogation of Wnt\/beta-catenin function. J Agric Food Chem. 2012;60(28):7031\u20139. https:\/\/doi.org\/10.1021\/jf301981n .","journal-title":"J Agric Food Chem"},{"issue":"1","key":"1186_CR19","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/mt.2010.216","volume":"19","author":"G Kallifatidis","year":"2011","unstructured":"Kallifatidis G, Labsch S, Rausch V, Mattern J, Gladkich J, Moldenhauer G, et al. Sulforaphane increases drug-mediated cytotoxicity toward cancer stem-like cells of pancreas and prostate. Mol Ther. 2011;19(1):188\u201395. https:\/\/doi.org\/10.1038\/mt.2010.216 .","journal-title":"Mol Ther"},{"issue":"10","key":"1186_CR20","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1158\/1535-7163.1239.3.10","volume":"3","author":"NA Pham","year":"2004","unstructured":"Pham NA, Jacobberger JW, Schimmer AD, Cao P, Gronda M, Hedley DW. The dietary isothiocyanate sulforaphane targets pathways of apoptosis, cell cycle arrest, and oxidative stress in human pancreatic cancer cells and inhibits tumor growth in severe combined immunodeficient mice. Mol Cancer Ther. 2004;3(10):1239\u201348.","journal-title":"Mol Cancer Ther"},{"key":"1186_CR21","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/978-1-61779-815-3_25","volume":"879","author":"S Schwarz","year":"2012","unstructured":"Schwarz S, Rotter N. Human salivary gland stem cells: isolation, propagation, and characterization. Methods Mol Biol (Clifton NJ). 2012;879:403\u201342. https:\/\/doi.org\/10.1007\/978-1-61779-815-3_25 .","journal-title":"Methods Mol Biol (Clifton NJ)"},{"key":"1186_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/jbm.b.33897","author":"MN Abdallah","year":"2017","unstructured":"Abdallah MN, Abdollahi S, Laurenti M, Fang D, Tran SD, Cerruti M, et al. Scaffolds for epithelial tissue engineering customized in elastomeric molds. J Biomed Mater Res Part B. 2017. https:\/\/doi.org\/10.1002\/jbm.b.33897 .","journal-title":"J Biomed Mater Res Part B"},{"key":"1186_CR23","unstructured":"Expasy.org. 2017. http:\/\/web.expasy.org\/cellosaurus\/ . Accessed 13 Sept 2017."},{"issue":"4","key":"1186_CR24","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/hed.21198","volume":"32","author":"JC Brenner","year":"2010","unstructured":"Brenner JC, Graham MP, Kumar B, Saunders LM, Kupfer R, Lyons RH, et al. Genotyping of 73 UM-SCC head and neck squamous cell carcinoma cell lines. Head Neck. 2010;32(4):417\u201326. https:\/\/doi.org\/10.1002\/hed.21198 .","journal-title":"Head Neck"},{"issue":"11","key":"1186_CR25","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1002\/1097-0142(19910601)67:11<2741::AID-CNCR2820671105>3.0.CO;2-S","volume":"67","author":"R Grenman","year":"1991","unstructured":"Grenman R, Carey TE, McClatchey KD, Wagner JG, Pekkola-Heino K, Schwartz DR, et al. In vitro radiation resistance among cell lines established from patients with squamous cell carcinoma of the head and neck. Cancer. 1991;67(11):2741\u20137.","journal-title":"Cancer"},{"issue":"6b","key":"1186_CR26","first-page":"2561","volume":"13","author":"TE Carey","year":"1993","unstructured":"Carey TE, Van Dyke DL, Worsham MJ. Nonrandom chromosome aberrations and clonal populations in head and neck cancer. Anticancer Res. 1993;13(6b):2561\u20137.","journal-title":"Anticancer Res"},{"issue":"6","key":"1186_CR27","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.oraloncology.2013.03.446","volume":"49","author":"R Nagel","year":"2013","unstructured":"Nagel R, Martens-de Kemp SR, Buijze M, Jacobs G, Braakhuis BJ, Brakenhoff RH. Treatment response of HPV-positive and HPV-negative head and neck squamous cell carcinoma cell lines. Oral Oncol. 2013;49(6):560\u20136. https:\/\/doi.org\/10.1016\/j.oraloncology.2013.03.446 .","journal-title":"Oral Oncol"},{"issue":"7","key":"1186_CR28","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1001\/archotol.1994.01880310054010","volume":"120","author":"K Pekkola-Heino","year":"1994","unstructured":"Pekkola-Heino K, Joensuu H, Klemi P, Grenman R. Relation of DNA ploidy and proliferation rate to radiation sensitivity in squamous carcinoma cell lines. Arch Otolaryngol. 1994;120(7):750\u20134.","journal-title":"Arch Otolaryngol"},{"issue":"8","key":"1186_CR29","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1002\/hed.10274","volume":"25","author":"CR Bradford","year":"2003","unstructured":"Bradford CR, Zhu S, Ogawa H, Ogawa T, Ubell M, Narayan A, et al. P53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines. Head Neck. 2003;25(8):654\u201361. https:\/\/doi.org\/10.1002\/hed.10274 .","journal-title":"Head Neck"},{"issue":"4","key":"1186_CR30","doi-asserted-by":"publisher","first-page":"e61555","DOI":"10.1371\/journal.pone.0061555","volume":"8","author":"SR Martens-de Kemp","year":"2013","unstructured":"Martens-de Kemp SR, Dalm SU, Wijnolts FM, Brink A, Honeywell RJ, Peters GJ, et al. DNA-bound platinum is the major determinant of cisplatin sensitivity in head and neck squamous carcinoma cells. PLoS ONE. 2013;8(4):e61555. https:\/\/doi.org\/10.1371\/journal.pone.0061555 .","journal-title":"PLoS ONE"},{"issue":"11","key":"1186_CR31","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1158\/1535-7163.MCT-12-0448","volume":"11","author":"L Wang","year":"2012","unstructured":"Wang L, Mosel AJ, Oakley GG, Peng A. Deficient DNA damage signaling leads to chemoresistance to cisplatin in oral cancer. Mol Cancer Ther. 2012;11(11):2401\u20139. https:\/\/doi.org\/10.1158\/1535-7163.mct-12-0448 .","journal-title":"Mol Cancer Ther"},{"issue":"Suppl 7","key":"1186_CR32","doi-asserted-by":"publisher","first-page":"vii252","DOI":"10.1093\/annonc\/mdq453","volume":"21","author":"JB Vermorken","year":"2010","unstructured":"Vermorken JB, Specenier P. Optimal treatment for recurrent\/metastatic head and neck cancer. Ann Oncol. 2010;21(Suppl 7):vii252\u201361. https:\/\/doi.org\/10.1093\/annonc\/mdq453 .","journal-title":"Ann Oncol"},{"issue":"1","key":"1186_CR33","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jfma.2016.01.004","volume":"116","author":"CM Liu","year":"2017","unstructured":"Liu CM, Peng CY, Liao YW, Lu MY, Tsai ML, Yeh JC, et al. Sulforaphane targets cancer stemness and tumor initiating properties in oral squamous cell carcinomas via miR-200c induction. J Formos Med Assoc. 2017;116(1):41\u20138. https:\/\/doi.org\/10.1016\/j.jfma.2016.01.004 .","journal-title":"J Formos Med Assoc"},{"issue":"1","key":"1186_CR34","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3164\/jcbn.09-65","volume":"46","author":"JH Kim","year":"2010","unstructured":"Kim JH, Han Kwon K, Jung JY, Han HS, Hyun Shim J, Oh SJ, et al. Sulforaphane increases cyclin-dependent kinase inhibitor, p21 protein in human oral carcinoma cells and nude mouse animal model to induce G(2)\/M cell cycle arrest. J Clin Biochem Nutr. 2010;46(1):60\u20137. https:\/\/doi.org\/10.3164\/jcbn.09-65 .","journal-title":"J Clin Biochem Nutr"},{"issue":"11","key":"1186_CR35","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1002\/ptr.3397","volume":"25","author":"HG Jee","year":"2011","unstructured":"Jee HG, Lee KE, Kim JB, Shin HK, Youn YK. Sulforaphane inhibits oral carcinoma cell migration and invasion in vitro. Phytother Res. 2011;25(11):1623\u20138. https:\/\/doi.org\/10.1002\/ptr.3397 .","journal-title":"Phytother Res"},{"issue":"12","key":"1186_CR36","doi-asserted-by":"publisher","first-page":"e51251","DOI":"10.1371\/journal.pone.0051251","volume":"7","author":"K Suppipat","year":"2012","unstructured":"Suppipat K, Park CS, Shen Y, Zhu X, Lacorazza HD. Sulforaphane induces cell cycle arrest and apoptosis in acute lymphoblastic leukemia cells. PLoS ONE. 2012;7(12):e51251. https:\/\/doi.org\/10.1371\/journal.pone.0051251 .","journal-title":"PLoS ONE"},{"issue":"5","key":"1186_CR37","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.phrs.2011.07.005","volume":"64","author":"JD Clarke","year":"2011","unstructured":"Clarke JD, Hsu A, Riedl K, Bella D, Schwartz SJ, Stevens JF, et al. Bioavailability and inter-conversion of sulforaphane and erucin in human subjects consuming broccoli sprouts or broccoli supplement in a cross-over study design. Pharmacol Res. 2011;64(5):456\u201363. https:\/\/doi.org\/10.1016\/j.phrs.2011.07.005 .","journal-title":"Pharmacol Res"},{"key":"1186_CR38","doi-asserted-by":"publisher","first-page":"36796","DOI":"10.1038\/srep36796","volume":"6","author":"X Wang","year":"2016","unstructured":"Wang X, Li Y, Dai Y, Liu Q, Ning S, Liu J, et al. Sulforaphane improves chemotherapy efficacy by targeting cancer stem cell-like properties via the miR-124\/IL-6R\/STAT3 axis. Sci Rep. 2016;6:36796. https:\/\/doi.org\/10.1038\/srep36796 .","journal-title":"Sci Rep"},{"issue":"6","key":"1186_CR39","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s12094-014-1162-1","volume":"16","author":"S Al-Dimassi","year":"2014","unstructured":"Al-Dimassi S, Abou-Antoun T, El-Sibai M. Cancer cell resistance mechanisms: a mini review. Clin Transl Oncol. 2014;16(6):511\u20136. https:\/\/doi.org\/10.1007\/s12094-014-1162-1 .","journal-title":"Clin Transl Oncol"},{"issue":"8","key":"1186_CR40","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.oraloncology.2008.07.003","volume":"45","author":"NP Cho","year":"2009","unstructured":"Cho NP, Han HS, Leem DH, Choi IS, Jung JY, Kim HJ, et al. Sulforaphane enhances caspase-dependent apoptosis through inhibition of cyclooxygenase-2 expression in human oral squamous carcinoma cells and nude mouse xenograft model. Oral Oncol. 2009;45(8):654\u201360. https:\/\/doi.org\/10.1016\/j.oraloncology.2008.07.003 .","journal-title":"Oral Oncol"},{"issue":"7","key":"1186_CR41","first-page":"2024","volume":"8","author":"CG Ferreira","year":"2002","unstructured":"Ferreira CG, Epping M, Kruyt FA, Giaccone G. Apoptosis: target of cancer therapy. Clin Cancer Res. 2002;8(7):2024\u201334.","journal-title":"Clin Cancer Res"},{"issue":"11","key":"1186_CR42","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1101\/gad.12.11.1551","volume":"12","author":"V Cryns","year":"1998","unstructured":"Cryns V, Yuan J. Proteases to die for. Genes Dev. 1998;12(11):1551\u201370.","journal-title":"Genes Dev"},{"issue":"1","key":"1186_CR43","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.imr.2013.12.001","volume":"3","author":"K-j Min","year":"2014","unstructured":"Min K-j, Kwon TK. Anticancer effects and molecular mechanisms of epigallocatechin-3-gallate. Integr Med Res. 2014;3(1):16\u201324. https:\/\/doi.org\/10.1016\/j.imr.2013.12.001 .","journal-title":"Integr Med Res"},{"issue":"5","key":"1186_CR44","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.7314\/APJCP.2012.13.5.2095","volume":"13","author":"JR Devi","year":"2012","unstructured":"Devi JR, Thangam EB. Mechanisms of anticancer activity of sulforaphane from Brassica oleracea in HEp-2 human epithelial carcinoma cell line. Asian Pac J Cancer Prevent. 2012;13(5):2095\u2013100.","journal-title":"Asian Pac J Cancer Prevent"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-018-1186-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-018-1186-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-018-1186-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,28]],"date-time":"2022-08-28T19:32:13Z","timestamp":1661715133000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-018-1186-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,4]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["1186"],"URL":"https:\/\/doi.org\/10.1007\/s12032-018-1186-4","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,4]]},"assertion":[{"value":"18 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"124"}}